Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Mordant

Showing results (21-30 of 131) with videos related to

Pageof 14
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 27, 2010
Advances in lung transplantation for cystic fibrosis that may improve outcomePierre Mordant, Pierre Bonnette, Philippe Puyo, et al.
The Annals of Thoracic Surgery|September 11, 2012
Characteristics and prognostic value of lymphatic and blood vascular microinvasion in lung cancerAlex Arame, Pierre Mordant, Aurélie Cazes, et al.
The Annals of Thoracic Surgery|March 12, 2013
Adenosquamous carcinoma of the lung: surgical management, pathologic characteristics, and prognostic implicationsPierre Mordant, Bertrand Grand, Aurélie Cazes, et al.
Cancer Treatment Reviews|May 27, 2011
Minimal residual disease in solid neoplasia: New frontier or red-herring?Pierre Mordant, Yohann Loriot, Benoît Lahon, et al.
Molecular Cancer Therapeutics|February 4, 2010
Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combinationPierre Mordant, Yohann Loriot, Céline Leteur, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 2, 2013
Long-term survival with surgery as part of a multimodality approach for N3 lung cancerMarc Riquet, Pierre Mordant, Elizabeth Fabre-Guillevin, et al.
Thoracic Surgery Clinics|April 10, 2013
Should all cases of lung cancer be presented at Tumor Board Conferences?Marc Riquet, Pierre Mordant, Mehdi Henni, et al.
Plos One|March 26, 2013
Isolated lung perfusion as an adjuvant treatment of colorectal cancer lung metastases: a preclinical study in a pig modelPierre-Benoit Pagès, Olivier Facy, Pierre Mordant, et al.
Scandinavian Journal of Infectious Diseases|January 24, 2014
Disseminated cryptococcosis, invasive aspergillosis, and mucormycosis in a patient treated with alemtuzumab for chronic lymphocytic leukaemiaAurélia Henn, Guillaume Mellon, Henry Benoît, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 19, 2011
Early severe digestive complications after lung transplantationBenoît Lahon, Pierre Mordant, Gabriel Thabut, et al.
Pageof 14

Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 27, 2010
Advances in lung transplantation for cystic fibrosis that may improve outcomePierre Mordant, Pierre Bonnette, Philippe Puyo, et al.
The Annals of Thoracic Surgery|September 11, 2012
Characteristics and prognostic value of lymphatic and blood vascular microinvasion in lung cancerAlex Arame, Pierre Mordant, Aurélie Cazes, et al.
The Annals of Thoracic Surgery|March 12, 2013
Adenosquamous carcinoma of the lung: surgical management, pathologic characteristics, and prognostic implicationsPierre Mordant, Bertrand Grand, Aurélie Cazes, et al.
Cancer Treatment Reviews|May 27, 2011
Minimal residual disease in solid neoplasia: New frontier or red-herring?Pierre Mordant, Yohann Loriot, Benoît Lahon, et al.
Molecular Cancer Therapeutics|February 4, 2010
Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combinationPierre Mordant, Yohann Loriot, Céline Leteur, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 2, 2013
Long-term survival with surgery as part of a multimodality approach for N3 lung cancerMarc Riquet, Pierre Mordant, Elizabeth Fabre-Guillevin, et al.
Thoracic Surgery Clinics|April 10, 2013
Should all cases of lung cancer be presented at Tumor Board Conferences?Marc Riquet, Pierre Mordant, Mehdi Henni, et al.
Plos One|March 26, 2013
Isolated lung perfusion as an adjuvant treatment of colorectal cancer lung metastases: a preclinical study in a pig modelPierre-Benoit Pagès, Olivier Facy, Pierre Mordant, et al.
Scandinavian Journal of Infectious Diseases|January 24, 2014
Disseminated cryptococcosis, invasive aspergillosis, and mucormycosis in a patient treated with alemtuzumab for chronic lymphocytic leukaemiaAurélia Henn, Guillaume Mellon, Henry Benoît, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 19, 2011
Early severe digestive complications after lung transplantationBenoît Lahon, Pierre Mordant, Gabriel Thabut, et al.
Pageof 14